Latest Breaking News On - Session date - Page 2 : comparemela.com

MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR

MiNK-215 eliminated MSS colorectal cancer liver metastases in human organoid modelsMiNK-215 exhibits potent anti-tumor activity through multiple mechanisms including immune activation NEW YORK, April.

United statesNew yorkSan diegoJennifer buellShanmugarajan krishnanAmerican association for cancer researchMink therapeutics incAmerican associationCancer researchChief executive officerSession dateMonday aprilRisk factors

Egle Therapeutics SAS: Egle Therapeutics to present novel immunocytokine preclinical data for EGL-001 with poster presentation at the 2024 AACR Annual Meeting

Egle Therapeutics SAS: Egle Therapeutics to present novel immunocytokine preclinical data for EGL-001 with poster presentation at the 2024 AACR Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDennis riedlAmerican association for cancer research annual meetingAegle therapeuticsAmerican associationCancer research annual meetingSession titleImmune modulationSession dateTuesday aprPoster sectionPoster board numberAbstract number

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj hicklinAmanda sellersverge scientific communicationsCompany contactAmerican association of immunologistsCompany or werewolf nasdaqExchange commissionWerewolf therapeutics incWerewolf therapeuticsAmerican associationChief executive officerSession dateNon hodgkin lymphomaNote regarding forward looking statementsthisPrivate securities litigation reform actJosh rappaportstern

Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting

Rallybio Corporation , a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases,.

New havenUnited statesAlloimmune thrombocytopeniaAndreav margulisRallybio corporation nasdaqOutcomes to support the developmentExchange commissionHealth solutionsAcademy of managed care pharmacyRallybio corporationManaged care pharmacyNew orleansNeonatal alloimmune thrombocytopeniaSystematic literature reviewAdverse pregnancy related outcomesNovel prophylactic therapeutic

Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented

Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented .

City ofUnited kingdomSouth africaCape townWestern capeCommunicationsnick bastinHana malikPoolbeg pharmaAmryt pharmaNiall gilchristPoolbeg pharma plcjeremy skillingtonPhil daviesJeremy skillingtonCeoian oconnellNigel birksLinkedin poolbegpharma